Disseminated tuberculosis complicating anti‐TNF‐α treatment
Summary An unusually large number of cases of tuberculosis, often of miliary or disseminated form, have been reported in patients receiving infliximab therapy for rheumatoid arthritis or Crohn's disease. We describe a patient with rheumatoid arthritis who was treated with infliximab and became...
Saved in:
| Published in | International journal of clinical practice (Esher) Vol. 58; no. 11; pp. 1052 - 1055 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK; Malden, USA
Blackwell Science Ltd
01.11.2004
Blackwell Hindawi Limited |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Summary
An unusually large number of cases of tuberculosis, often of miliary or disseminated form, have been reported in patients receiving infliximab therapy for rheumatoid arthritis or Crohn's disease. We describe a patient with rheumatoid arthritis who was treated with infliximab and became systemically ill with Mycobacterium tuberculosis‐disseminated infection. Patients who are candidates for treatment with tumour necrosis factor‐alfa inhibitors should be evaluated for the presence of latent or active M. tuberculosis infection. |
|---|---|
| AbstractList | An unusually large number of cases of tuberculosis, often of miliary or disseminated form, have been reported in patients receiving infliximab therapy for rheumatoid arthritis or Crohn's disease. We describe a patient with rheumatoid arthritis who was treated with infliximab and became systemically ill with Mycobacterium tuberculosis-disseminated infection. Patients who are candidates for treatment with tumour necrosis factor-alfa inhibitors should be evaluated for the presence of latent or active Summary An unusually large number of cases of tuberculosis, often of miliary or disseminated form, have been reported in patients receiving infliximab therapy for rheumatoid arthritis or Crohn's disease. We describe a patient with rheumatoid arthritis who was treated with infliximab and became systemically ill with Mycobacterium tuberculosis‐disseminated infection. Patients who are candidates for treatment with tumour necrosis factor‐alfa inhibitors should be evaluated for the presence of latent or active M. tuberculosis infection. An unusually large number of cases of tuberculosis, often of miliary or disseminated form, have been reported in patients receiving infliximab therapy for rheumatoid arthritis or Crohn's disease. We describe a patient with rheumatoid arthritis who was treated with infliximab and became systemically ill with Mycobacterium tuberculosis-disseminated infection. Patients who are candidates for treatment with tumour necrosis factor-alfa inhibitors should be evaluated for the presence of latent or active M. tuberculosis infection.[PUBLICATION ABSTRACT] |
| Author | Latsi, P. Dimakou, K. Papaioannides, D. Katsimboula, S. Orphanidou, D. Korantzopoulos, P. |
| Author_xml | – sequence: 1 givenname: K. surname: Dimakou fullname: Dimakou, K. – sequence: 2 givenname: D. surname: Papaioannides fullname: Papaioannides, D. – sequence: 3 givenname: P. surname: Latsi fullname: Latsi, P. – sequence: 4 givenname: S. surname: Katsimboula fullname: Katsimboula, S. – sequence: 5 givenname: P. surname: Korantzopoulos fullname: Korantzopoulos, P. – sequence: 6 givenname: D. surname: Orphanidou fullname: Orphanidou, D. |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16350110$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15605672$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkE1O3DAYhi0E4v8KKEJqdwmff-MskIoGaEEIuqBry_E4lUeJM7UTFXYcgav0Ij0EJ8FhRkViVS_sT_LzvXr17KFN33uLUIahwOmcLApcMpJjwnBBAFgBAAIXDxto99_HZpqpkDkHinfQXowLAMK5hG20g7kALkqyi76cuxht57we7DwbxtoGM7Z9dDEzfbdsndGD8z8z7Qf38vR8f3uZ7r9_siFYPXTWDwdoq9FttIfrdx_9uLy4n33Lb-6-Xs3ObnLDUpmcCV0BBlGZUkowrNblvJ6bWjNmGqobaqnkzFTATcUaRjSxNQgpOG5qQQWh--jzKncZ-l-jjYPqXDS2bbW3_RiVKLGEUsgEHn8AF_0YfOqmCKkqQiif0uQKMqGPMdhGLYPrdHhUGNSkWC3UZFJNJtWkWL0pVg9p9WidP9adnb8vrp0m4NMa0NHotgnaGxffOUE5YAyJO11xv11rH_-7gLq6nn1PE30FIWWaCQ |
| CitedBy_id | crossref_primary_10_1007_s10067_010_1466_7 crossref_primary_10_1016_j_jaad_2007_08_030 crossref_primary_10_1371_journal_pone_0025121 crossref_primary_10_1007_s12275_010_0038_5 crossref_primary_10_1099_mic_0_29290_0 crossref_primary_10_1517_14656566_7_14_1907 crossref_primary_10_1016_j_tube_2010_08_005 crossref_primary_10_1021_acs_jnatprod_6b00869 crossref_primary_10_15406_mojcr_2017_07_00218 crossref_primary_10_1007_s00393_005_0018_z crossref_primary_10_1002_hep_21257 crossref_primary_10_1111_j_1600_0757_2009_00304_x crossref_primary_10_1007_s10067_008_0867_3 crossref_primary_10_1016_j_rmcr_2014_09_005 crossref_primary_10_1016_S1726_4901_09_70433_2 crossref_primary_10_1093_ofid_ofab641 crossref_primary_10_1016_j_tube_2018_08_012 crossref_primary_10_2353_ajpath_2006_060681 crossref_primary_10_1002_art_22077 crossref_primary_10_1016_j_cgh_2006_05_031 crossref_primary_10_1053_j_gastro_2006_08_022 crossref_primary_10_1177_247553031319a00101 crossref_primary_10_1016_j_jdcr_2022_08_048 crossref_primary_10_1002_art_27271 |
| Cites_doi | 10.1038/labinvest.3780094 10.1093/rheumatology/41.2.231 10.1016/1074-7613(95)90001-2 10.1186/ar564 10.1016/S0049-0172(95)80009-3 10.1016/S0248-8663(01)00556-2 10.1016/S1297-319X(02)00387-1 10.1093/infdis/170.5.1229 10.4049/jimmunol.152.2.743 10.1016/S0140-6736(99)05246-0 10.1016/S0002-9343(01)01035-X 10.4049/jimmunol.161.5.2636 10.1056/NEJM200011303432202 10.1080/030097402317255372 10.1093/rheumatology/41.10.1126 10.1016/0954-6111(93)90001-G 10.1164/ajrccm.150.1.8025760 10.1128/IAI.59.9.3213-3218.1991 10.1128/IAI.69.3.1847-1855.2001 10.1016/S0002-9343(01)00945-7 10.1016/S0002-9343(02)01205-6 10.1136/pmj.77.909.436 10.1056/NEJMoa011110 10.1111/j.1572-0241.2001.03836.x |
| ContentType | Journal Article |
| Copyright | 2005 INIST-CNRS Copyright Blackwell Publishing Nov 2004 |
| Copyright_xml | – notice: 2005 INIST-CNRS – notice: Copyright Blackwell Publishing Nov 2004 |
| DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T5 7TK 7TS 7U9 H94 K9. NAPCQ 7X8 |
| DOI | 10.1111/j.1742-1241.2004.00061.x |
| DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Calcium & Calcified Tissue Abstracts Immunology Abstracts Neurosciences Abstracts Physical Education Index Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Nursing & Allied Health Premium Virology and AIDS Abstracts AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Immunology Abstracts Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Physical Education Index MEDLINE - Academic |
| DatabaseTitleList | MEDLINE Nursing & Allied Health Premium |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1742-1241 |
| EndPage | 1055 |
| ExternalDocumentID | 876383761 10_1111_j_1742_1241_2004_00061_x 15605672 16350110 IJCP061 |
| Genre | caseStudy Journal Article Case Reports |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1OC 24P 29J 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAJEY AAONW AAWTL AAZKR ABCQN ABCUV ABEML ABJNI ABPVW ACAHQ ACBWZ ACCFJ ACGFO ACGFS ACMXC ACPOU ACPRK ACSCC ACXQS ADBBV ADEOM ADIYS ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFEBI AFFNX AFGKR AFPWT AFRAH AFZJQ AHMBA AIACR AIAGR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN EX3 F00 F01 F04 F5P FEDTE FUBAC G-S G.N GODZA GROUPED_DOAJ H.X HF~ HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PGMZT PQQKQ Q.N Q11 QB0 R.K RHX ROL RPM RX1 SUPJJ TEORI UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI X7M XG1 ZGI ZXP ZZTAW ~IA ~WT AAPBV AAUGY AAVGM ABHUG ACXME ADAWD AFVGU AGJLS AJAOE AKALU IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QP 7T5 7TK 7TS 7U9 H94 K9. NAPCQ 7X8 |
| ID | FETCH-LOGICAL-c4241-46a901069c7880c4ba7dbdcba44cf3af3e3854c905c94f42a2eb068651fb63623 |
| IEDL.DBID | DR2 |
| ISSN | 1368-5031 |
| IngestDate | Fri Aug 16 08:42:34 EDT 2024 Thu Oct 10 16:18:49 EDT 2024 Fri Aug 23 02:43:45 EDT 2024 Sat Sep 28 07:45:49 EDT 2024 Sun Oct 29 17:09:02 EDT 2023 Sat Aug 24 01:16:40 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Infection Medicine Treatment Tuberculosis Bacteriosis Complication Mycobacterial infection Disseminated Tumor necrosis factor α |
| Language | English |
| License | CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4241-46a901069c7880c4ba7dbdcba44cf3af3e3854c905c94f42a2eb068651fb63623 |
| Notes | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| PMID | 15605672 |
| PQID | 229922352 |
| PQPubID | 28147 |
| PageCount | 4 |
| ParticipantIDs | proquest_miscellaneous_67180768 proquest_journals_229922352 crossref_primary_10_1111_j_1742_1241_2004_00061_x pubmed_primary_15605672 pascalfrancis_primary_16350110 wiley_primary_10_1111_j_1742_1241_2004_00061_x_IJCP061 |
| PublicationCentury | 2000 |
| PublicationDate | November 2004 |
| PublicationDateYYYYMMDD | 2004-11-01 |
| PublicationDate_xml | – month: 11 year: 2004 text: November 2004 |
| PublicationDecade | 2000 |
| PublicationPlace | Oxford, UK; Malden, USA |
| PublicationPlace_xml | – name: Oxford, UK; Malden, USA – name: Oxford – name: England – name: London |
| PublicationTitle | International journal of clinical practice (Esher) |
| PublicationTitleAlternate | Int J Clin Pract |
| PublicationYear | 2004 |
| Publisher | Blackwell Science Ltd Blackwell Hindawi Limited |
| Publisher_xml | – name: Blackwell Science Ltd – name: Blackwell – name: Hindawi Limited |
| References | 1991; 59 1994; 170 2002; 31 2002; 113 1994; 152 1993; 87 1994; 150 2002; 112 1999; 46 2002; 4 1995; 2 2001; 69 2001; 345 1998; 16 2002; 69 2002; 29 2002; 41 2000; 59 2002; 61 2002; 146 2002; 23 1995; 24 2000; 80 1999; 354 2000; 343 2001; 77 2001; 96 1998; 161 Maini (10.1111/j.1742-1241.2004.00061.x-BIB2|cit2) 1999; 354 Salmon (10.1111/j.1742-1241.2004.00061.x-BIB31|cit31) 2002; 69 Vonkeman (10.1111/j.1742-1241.2004.00061.x-BIB16|cit16) 2002; 146 Mohan (10.1111/j.1742-1241.2004.00061.x-BIB27|cit27) 2001; 69 Mayordomo (10.1111/j.1742-1241.2004.00061.x-BIB12|cit12) 2002; 31 Wagner (10.1111/j.1742-1241.2004.00061.x-BIB10|cit10) 2002; 112 Markman (10.1111/j.1742-1241.2004.00061.x-BIB5|cit5) 2000; 59 Roth (10.1111/j.1742-1241.2004.00061.x-BIB14|cit14) 2002; 23 Lorenz (10.1111/j.1742-1241.2004.00061.x-BIB1|cit1) 2002; 4 Lipsky (10.1111/j.1742-1241.2004.00061.x-BIB19|cit19) 2000; 343 Hirsch (10.1111/j.1742-1241.2004.00061.x-BIB30|cit30) 1994; 152 Derksen (10.1111/j.1742-1241.2004.00061.x-BIB8|cit8) 2002; 146 Flesch (10.1111/j.1742-1241.2004.00061.x-BIB26|cit26) 1991; 59 Shergy (10.1111/j.1742-1241.2004.00061.x-BIB13|cit13) 2002; 29 LeMense (10.1111/j.1742-1241.2004.00061.x-BIB18|cit18) 1994; 150 Conroy (10.1111/j.1742-1241.2004.00061.x-BIB3|cit3) 2001; 77 Liberopoulos (10.1111/j.1742-1241.2004.00061.x-BIB15|cit15) 2002; 113 Rovere Querini (10.1111/j.1742-1241.2004.00061.x-BIB11|cit11) 2002; 41 Kim (10.1111/j.1742-1241.2004.00061.x-BIB20|cit20) 1998; 16 Jacobs (10.1111/j.1742-1241.2004.00061.x-BIB23|cit23) 2000; 80 Bartolucci (10.1111/j.1742-1241.2004.00061.x-BIB4|cit4) 2002; 41 Bateman (10.1111/j.1742-1241.2004.00061.x-BIB21|cit21) 1993; 87 Furst (10.1111/j.1742-1241.2004.00061.x-BIB32|cit32) 2002; 61 Szatmary (10.1111/j.1742-1241.2004.00061.x-BIB22|cit22) 1999; 46 Balcewitz-Sablinska (10.1111/j.1742-1241.2004.00061.x-BIB24|cit24) 1998; 161 Nunez Martinez (10.1111/j.1742-1241.2004.00061.x-BIB9|cit9) 2001; 96 Boerbooms (10.1111/j.1742-1241.2004.00061.x-BIB17|cit17) 1995; 24 Nakelchik (10.1111/j.1742-1241.2004.00061.x-BIB25|cit25) 2002; 112 Hirsch (10.1111/j.1742-1241.2004.00061.x-BIB29|cit29) 1994; 170 Flynn (10.1111/j.1742-1241.2004.00061.x-BIB28|cit28) 1995; 2 Daniel (10.1111/j.1742-1241.2004.00061.x-BIB7|cit7) 2002; 29 Keane (10.1111/j.1742-1241.2004.00061.x-BIB6|cit6) 2001; 345 |
| References_xml | – volume: 29 start-page: 667 year: 2002 end-page: 77 article-title: Open‐label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis publication-title: J Rheumatol – volume: 96 start-page: 1665 year: 2001 end-page: 6 article-title: Reactivation tuberculosis in a patient with anti‐TNF‐alpha treatment publication-title: Am J Gastroenterol – volume: 161 start-page: 2636 year: 1998 end-page: 41 article-title: Pathogenic evades apoptosis of host macrophages by release of TNF‐R2, resulting in inactivation of TNF‐alpha publication-title: J Immunol – volume: 354 start-page: 1932 year: 1999 end-page: 9 article-title: Infliximab (chimeric anti‐tumour necrosis factor monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial publication-title: Lancet – volume: 343 start-page: 1594 year: 2000 end-page: 602 article-title: Infliximab and methotrexate in the treatment of rheumatoid arthritis publication-title: N Engl J Med – volume: 113 start-page: 615 year: 2002 article-title: Exacerbation of tuberculosis enteritis after treatment with infliximab publication-title: Am J Med – volume: 152 start-page: 743 year: 1994 end-page: 53 article-title: Complement receptor‐mediated uptake and tumor necrosis factor‐α‐mediated growth inhibition of by human alveolar macrophages publication-title: J Immunol – volume: 69 start-page: 170 year: 2002 end-page: 2 article-title: Recommendations about the prevention and management of tuberculosis in patients taking infliximab publication-title: Joint Bone Spine – volume: 4 start-page: S17 issue: Suppl. 3 year: 2002 end-page: S24 article-title: Perspectives for TNF‐α‐targeting therapies publication-title: Arthritis Res – volume: 61 start-page: 1162 issue: Suppl. 11 year: 2002 end-page: 3 article-title: Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents publication-title: Ann Rheum Dis – volume: 46 start-page: 257 year: 1999 end-page: 66 article-title: Tumor necrosis factor‐α: molecular‐biological aspects publication-title: Neoplasma – volume: 146 start-page: 1165 year: 2002 end-page: 8 article-title: The treatment of chronic inflammatory diseases with monoclonal antibodies against tumor necrosis factor: side effects, contraindications and precautions publication-title: Ned Tijdschr Geneeskd – volume: 31 start-page: 44 year: 2002 end-page: 5 article-title: Pulmonary miliary tuberculosis in a patient with anti‐TNF‐alpha treatment publication-title: Scand J Rheumatol – volume: 16 start-page: 9 year: 1998 end-page: 13 article-title: infection in a corticosteroid‐treated rheumatic disease patient population publication-title: Clin Exp Rheumatol – volume: 150 start-page: 258 year: 1994 end-page: 60 article-title: Opportunistic infection during treatment with low dose methotrexate publication-title: Am J Respir Crit Care Med – volume: 87 start-page: 485 year: 1993 end-page: 7 article-title: Is tuberculous chemoprophylaxis necessary for patients receiving corticosteroids for respiratory disease? publication-title: Respir Med – volume: 345 start-page: 1098 year: 2001 end-page: 104 article-title: Tuberculosis associated with infliximab, a tumor necrosis factor ‐neutralizing agent publication-title: N Engl J Med – volume: 24 start-page: 411 year: 1995 end-page: 21 article-title: Infections during low dose methotrexate treatment in rheumatoid arthritis publication-title: Semin Arthritis Rheum – volume: 170 start-page: 1229 year: 1994 end-page: 37 article-title: Enhancement of intracellular growth of in human monocytes by transforming growth factor beta publication-title: J Infect Dis – volume: 59 start-page: 134 year: 2000 end-page: 59 article-title: Ifliximab. A review of its use in the management of rheumatoid arthritis publication-title: Drugs – volume: 2 start-page: 561 year: 1995 end-page: 72 article-title: Tumor necrosis factor‐α is required in the protective immune response against in mice publication-title: Immunity – volume: 41 start-page: 1126 year: 2002 end-page: 32 article-title: Efficacy of the anti‐TNF‐α antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients publication-title: Rheumatology (Oxford) – volume: 29 start-page: 647 year: 2002 end-page: 9 article-title: Infliximab: additional safety data from an open label study publication-title: J Rheumatol – volume: 112 start-page: 67 year: 2002 end-page: 9 article-title: Exacerbation of enteritis masquerading as Crohn's disease after treatment with a tumor necrosis‐α inhibitor publication-title: Am J Med – volume: 77 start-page: 436 year: 2001 end-page: 40 article-title: Infliximab treatment for Crohn's disease publication-title: Postgrad Med J – volume: 146 start-page: 1165 year: 2002 end-page: 8 article-title: Fatal miliary tuberculosis during treatment with infliximab publication-title: Ned Tijdschr Geneeskd – volume: 23 start-page: 312 year: 2002 end-page: 6 article-title: Anti‐TNF alpha monoclonal antibodies (infliximab) and tuberculosis: apropos of 3 cases publication-title: Rev Med Interne – volume: 112 start-page: 78 year: 2002 article-title: Reactivation of histoplasmosis after treatment with infliximab publication-title: Am J Med – volume: 59 start-page: 3213 year: 1991 end-page: 8 article-title: Mechanisms involved in mycobacterial growth inhibition by gamma interferon‐activated bone marrow macrophages: role of reactive nitrogen intermediates publication-title: Infect Immun – volume: 80 start-page: 901 year: 2000 end-page: 14 article-title: Correction of defective host response to BCG infection in TNF‐deficient mice by bone marrow transplantation publication-title: Lab Invest – volume: 41 start-page: 231 year: 2002 article-title: Miliary tuberculosis after biological therapy for rheumatoid arthritis publication-title: Rheumatology (Oxford) – volume: 69 start-page: 1847 year: 2001 end-page: 55 article-title: Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: possible role for limited pathology publication-title: Infect Immun – volume: 80 start-page: 901 year: 2000 ident: 10.1111/j.1742-1241.2004.00061.x-BIB23|cit23 article-title: Correction of defective host response to Mycobacterium bovis BCG infection in TNF-deficient mice by bone marrow transplantation publication-title: Lab Invest doi: 10.1038/labinvest.3780094 contributor: fullname: Jacobs – volume: 41 start-page: 231 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB11|cit11 article-title: Miliary tuberculosis after biological therapy for rheumatoid arthritis publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/41.2.231 contributor: fullname: Rovere Querini – volume: 146 start-page: 1165 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB16|cit16 article-title: Fatal miliary tuberculosis during treatment with infliximab publication-title: Ned Tijdschr Geneeskd contributor: fullname: Vonkeman – volume: 2 start-page: 561 year: 1995 ident: 10.1111/j.1742-1241.2004.00061.x-BIB28|cit28 article-title: Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice publication-title: Immunity doi: 10.1016/1074-7613(95)90001-2 contributor: fullname: Flynn – volume: 4 start-page: S17 issue: Suppl. 3 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB1|cit1 article-title: Perspectives for TNF-α-targeting therapies publication-title: Arthritis Res doi: 10.1186/ar564 contributor: fullname: Lorenz – volume: 61 start-page: 1162 issue: Suppl. 11 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB32|cit32 article-title: Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents publication-title: Ann Rheum Dis contributor: fullname: Furst – volume: 24 start-page: 411 year: 1995 ident: 10.1111/j.1742-1241.2004.00061.x-BIB17|cit17 article-title: Infections during low dose methotrexate treatment in rheumatoid arthritis publication-title: Semin Arthritis Rheum doi: 10.1016/S0049-0172(95)80009-3 contributor: fullname: Boerbooms – volume: 23 start-page: 312 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB14|cit14 article-title: Anti-TNF alpha monoclonal antibodies (infliximab) and tuberculosis: apropos of 3 cases publication-title: Rev Med Interne doi: 10.1016/S0248-8663(01)00556-2 contributor: fullname: Roth – volume: 16 start-page: 9 year: 1998 ident: 10.1111/j.1742-1241.2004.00061.x-BIB20|cit20 article-title: Mycobacterium tuberculosis infection in a corticosteroid-treated rheumatic disease patient population publication-title: Clin Exp Rheumatol contributor: fullname: Kim – volume: 69 start-page: 170 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB31|cit31 article-title: Recommendations about the prevention and management of tuberculosis in patients taking infliximab publication-title: Joint Bone Spine doi: 10.1016/S1297-319X(02)00387-1 contributor: fullname: Salmon – volume: 170 start-page: 1229 year: 1994 ident: 10.1111/j.1742-1241.2004.00061.x-BIB29|cit29 article-title: Enhancement of intracellular growth of M. tuberculosis in human monocytes by transforming growth factor beta publication-title: J Infect Dis doi: 10.1093/infdis/170.5.1229 contributor: fullname: Hirsch – volume: 152 start-page: 743 year: 1994 ident: 10.1111/j.1742-1241.2004.00061.x-BIB30|cit30 article-title: Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages publication-title: J Immunol doi: 10.4049/jimmunol.152.2.743 contributor: fullname: Hirsch – volume: 354 start-page: 1932 year: 1999 ident: 10.1111/j.1742-1241.2004.00061.x-BIB2|cit2 article-title: Infliximab (chimeric anti-tumour necrosis factor monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomized phase III trial publication-title: Lancet doi: 10.1016/S0140-6736(99)05246-0 contributor: fullname: Maini – volume: 112 start-page: 67 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB10|cit10 article-title: Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis-α inhibitor publication-title: Am J Med doi: 10.1016/S0002-9343(01)01035-X contributor: fullname: Wagner – volume: 46 start-page: 257 year: 1999 ident: 10.1111/j.1742-1241.2004.00061.x-BIB22|cit22 article-title: Tumor necrosis factor-α: molecular-biological aspects publication-title: Neoplasma contributor: fullname: Szatmary – volume: 161 start-page: 2636 year: 1998 ident: 10.1111/j.1742-1241.2004.00061.x-BIB24|cit24 article-title: Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha publication-title: J Immunol doi: 10.4049/jimmunol.161.5.2636 contributor: fullname: Balcewitz-Sablinska – volume: 29 start-page: 647 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB7|cit7 article-title: Infliximab: additional safety data from an open label study publication-title: J Rheumatol contributor: fullname: Daniel – volume: 146 start-page: 1165 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB8|cit8 article-title: The treatment of chronic inflammatory diseases with monoclonal antibodies against tumor necrosis factor: side effects, contraindications and precautions publication-title: Ned Tijdschr Geneeskd contributor: fullname: Derksen – volume: 343 start-page: 1594 year: 2000 ident: 10.1111/j.1742-1241.2004.00061.x-BIB19|cit19 article-title: Infliximab and methotrexate in the treatment of rheumatoid arthritis publication-title: N Engl J Med doi: 10.1056/NEJM200011303432202 contributor: fullname: Lipsky – volume: 31 start-page: 44 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB12|cit12 article-title: Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment publication-title: Scand J Rheumatol doi: 10.1080/030097402317255372 contributor: fullname: Mayordomo – volume: 29 start-page: 667 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB13|cit13 article-title: Open-label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis publication-title: J Rheumatol contributor: fullname: Shergy – volume: 41 start-page: 1126 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB4|cit4 article-title: Efficacy of the anti-TNF-α antibody infliximab against refractory systemic vasculitides: an open pilot study on 10 patients publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/41.10.1126 contributor: fullname: Bartolucci – volume: 87 start-page: 485 year: 1993 ident: 10.1111/j.1742-1241.2004.00061.x-BIB21|cit21 article-title: Is tuberculous chemoprophylaxis necessary for patients receiving corticosteroids for respiratory disease? publication-title: Respir Med doi: 10.1016/0954-6111(93)90001-G contributor: fullname: Bateman – volume: 150 start-page: 258 year: 1994 ident: 10.1111/j.1742-1241.2004.00061.x-BIB18|cit18 article-title: Opportunistic infection during treatment with low dose methotrexate publication-title: Am J Respir Crit Care Med doi: 10.1164/ajrccm.150.1.8025760 contributor: fullname: LeMense – volume: 59 start-page: 3213 year: 1991 ident: 10.1111/j.1742-1241.2004.00061.x-BIB26|cit26 article-title: Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates publication-title: Infect Immun doi: 10.1128/IAI.59.9.3213-3218.1991 contributor: fullname: Flesch – volume: 69 start-page: 1847 year: 2001 ident: 10.1111/j.1742-1241.2004.00061.x-BIB27|cit27 article-title: Effects of tumor necrosis factor α on host immune response in chronic persistent tuberculosis: possible role for limited pathology publication-title: Infect Immun doi: 10.1128/IAI.69.3.1847-1855.2001 contributor: fullname: Mohan – volume: 112 start-page: 78 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB25|cit25 article-title: Reactivation of histoplasmosis after treatment with infliximab publication-title: Am J Med doi: 10.1016/S0002-9343(01)00945-7 contributor: fullname: Nakelchik – volume: 113 start-page: 615 year: 2002 ident: 10.1111/j.1742-1241.2004.00061.x-BIB15|cit15 article-title: Exacerbation of tuberculosis enteritis after treatment with infliximab publication-title: Am J Med doi: 10.1016/S0002-9343(02)01205-6 contributor: fullname: Liberopoulos – volume: 77 start-page: 436 year: 2001 ident: 10.1111/j.1742-1241.2004.00061.x-BIB3|cit3 article-title: Infliximab treatment for Crohn's disease publication-title: Postgrad Med J doi: 10.1136/pmj.77.909.436 contributor: fullname: Conroy – volume: 59 start-page: 134 year: 2000 ident: 10.1111/j.1742-1241.2004.00061.x-BIB5|cit5 article-title: Ifliximab. A review of its use in the management of rheumatoid arthritis publication-title: Drugs contributor: fullname: Markman – volume: 345 start-page: 1098 year: 2001 ident: 10.1111/j.1742-1241.2004.00061.x-BIB6|cit6 article-title: Tuberculosis associated with infliximab, a tumor necrosis factor -neutralizing agent publication-title: N Engl J Med doi: 10.1056/NEJMoa011110 contributor: fullname: Keane – volume: 96 start-page: 1665 year: 2001 ident: 10.1111/j.1742-1241.2004.00061.x-BIB9|cit9 article-title: Reactivation tuberculosis in a patient with anti-TNF-alpha treatment publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2001.03836.x contributor: fullname: Nunez Martinez |
| SSID | ssj0025580 |
| Score | 1.8947972 |
| Snippet | Summary
An unusually large number of cases of tuberculosis, often of miliary or disseminated form, have been reported in patients receiving infliximab therapy... An unusually large number of cases of tuberculosis, often of miliary or disseminated form, have been reported in patients receiving infliximab therapy for... |
| SourceID | proquest crossref pubmed pascalfrancis wiley |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 1052 |
| SubjectTerms | Antibodies, Monoclonal Antirheumatic Agents anti‐TNF‐α treatment Arthritis, Rheumatoid - drug therapy Bacterial diseases Biological and medical sciences Case studies Contraindications Drug therapy Female General aspects Human bacterial diseases Humans Infectious diseases Infliximab Medical sciences Medical treatment Middle Aged Miliary tuberculosis Opportunistic Infections - complications Opportunistic Infections - diagnostic imaging Rheumatoid arthritis Tomography, X-Ray Computed Tuberculosis Tuberculosis and atypical mycobacterial infections Tuberculosis, Miliary - complications Tuberculosis, Miliary - diagnostic imaging Tuberculosis, Pulmonary - complications Tuberculosis, Pulmonary - diagnostic imaging Tumor Necrosis Factor-alpha - antagonists & inhibitors |
| Title | Disseminated tuberculosis complicating anti‐TNF‐α treatment |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1742-1241.2004.00061.x https://www.ncbi.nlm.nih.gov/pubmed/15605672 https://www.proquest.com/docview/229922352 https://search.proquest.com/docview/67180768 |
| Volume | 58 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEB7Egwji-1Efaw9eu2y7adrelNVFBUVEwVtI0lRE6S52C-LJn-Bf8Y_4I_wlzjTdXVc8iHgphZKQziPzTeYRgD1p4lC1Qu35UWw83CV9TxqZeAla8zjVgYmqOyPPzvnxNTu9CW_q_CeqhbH9IUYHbqQZ1X5NCi5VMank6NZ5aJ-sm9eszHGT8CT11SN8dDnqJIXAObYFw1RohIL8Pannh4kmLNVcXxZItMzedvETHJ1Et5V56i7A_fDHbFbKfbMcqKZ-_tbz8X_-fBHmaxTrHlixW4Ipky_DzFkdp1-B_UMK81OWDQJad1Aq86jLh15xV7jjHPb81kW23n28vF6dd_H5_uaO0t5X4bp7dNU59uq7GjzNcB0e45ISPXii0aduaaZklKpUK8mYztoya5t2HDKdoFgkLGOBDIyi6pTQzxRHI9peg-m8l5sNcLWOUp4Z9EwjxZIUXeiYx2nK_cz4qVHSAX_IF9G3LTnEF1cGSSOINHTBJhMVacSTA40JBo4Hcoqs-i0HtoYcFbUWFyIIqGsvQlQHdkdfUf0opiJz0ysLwdG2UzDTgXUrBuOZEUuGPMKxvGLmr9cqTk47F_i2-deBWzBr21HSQdE2TA8eS7OD0GmgGpVSfAK9UAtO |
| link.rule.ids | 315,786,790,1382,27955,27956,46751 |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fS-NAEB_EAxXkTk_vzHlqHnxNadLNJnlT9Err2SJSwbdld7M55CQV04D45Efwq_hF_BB-EmeyaWulD4fcSwiEXTYzOzu_2fkHsC9NHKpmqD0_io2Hp6TvSSMTL0FtHqc6MFHVM7LX550LdnIZXtbtgCgXxtaHmFy4kWRU5zUJOF1Iz0o52nUeKihr5zUqfdxAQPkJpT8kKT0-n9SSQugc25RhSjXCrfw-rGfOTDO6avVGFki2zPa7mAdIZ_FtpaDaX-B6_Gs2LuVvoxyphr5_V_XxP_37Gnyugax7aHfeOiyY_Css9WpX_QYcHJOnnwJtENO6o1KZW11eD4urwp2Gsed_XOTs1cvD46DfxufzkzuJfN-Ei_avwVHHq9s1eJrhOjzGJcV68ESjWd3UTMkoValWkjGdtWTWMq04ZDrBnZGwjAUyMIoSVEI_Uxz1aOsbLObD3GyBq3WU8sygcRoplqRoRcc8TlPuZ8ZPjZIO-GPGiBtblUO8sWaQNIJIQz02mahII-4c2J3h4HQgJ-eq33Rge8xSUQtyIYKACvciSnVgb_IVJZDcKjI3w7IQHNU7-TMd-G73wXRmhJMhj3Asr7j5z2sV3ZOjM3z78dGBe7DcGfROxWm3_3sbVmx1Sro3-gmLo9vS7CCSGqndSkJeAYaOD24 |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Disseminated+tuberculosis+complicating+anti-TNF-%CE%B1+treatment&rft.jtitle=International+journal+of+clinical+practice+%28Esher%29&rft.au=DIMAKOU%2C+K&rft.au=PAPAIOANNIDES%2C+D&rft.au=LATSI%2C+P&rft.au=KATSIMBOULA%2C+S&rft.date=2004-11-01&rft.pub=Blackwell&rft.issn=1368-5031&rft.eissn=1742-1241&rft.volume=58&rft.issue=11&rft.spage=1052&rft.epage=1055&rft_id=info:doi/10.1111%2Fj.1742-1241.2004.00061.x&rft.externalDBID=n%2Fa&rft.externalDocID=16350110 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1368-5031&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1368-5031&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1368-5031&client=summon |